Roychoudhuri et al. [39] researched whether BACH2 could promote the growth of tumors by Treg-mediated inhibition of CD8+ T cells as well as concomitant IFN-γ-dependent effector mechanisms in melanoma and lymphoma. The gene discussed is BACH2; the disease is lymphoma.